Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Assets Average (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Assets Average for 12 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average fell 25.22% to $20.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.9 million, a 25.22% decrease, with the full-year FY2025 number at $23.4 million, down 15.85% from a year prior.
  • Assets Average was $20.9 million for Q4 2025 at Ekso Bionics Holdings, down from $22.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $54.7 million in Q2 2021 to a low of $20.9 million in Q4 2025.
  • A 5-year average of $35.5 million and a median of $34.1 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: skyrocketed 126.62% in 2021, then dropped 25.81% in 2024.
  • Ekso Bionics Holdings' Assets Average stood at $49.9 million in 2021, then decreased by 19.7% to $40.1 million in 2022, then fell by 25.07% to $30.1 million in 2023, then dropped by 7.05% to $27.9 million in 2024, then fell by 25.22% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Assets Average are $20.9 million (Q4 2025), $22.4 million (Q3 2025), and $25.2 million (Q2 2025).